BioLargo, Inc.
BLGO
$0.202
-$0.0027-1.32%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.29M | 17.78M | 18.50M | 16.82M | 13.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.29M | 17.78M | 18.50M | 16.82M | 13.25M |
| Cost of Revenue | 9.19M | 9.93M | 10.30M | 8.91M | 6.66M |
| Gross Profit | 7.10M | 7.86M | 8.19M | 7.91M | 6.59M |
| SG&A Expenses | 9.64M | 9.30M | 8.99M | 9.17M | 8.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -1.00K | -42.00K | 13.00K |
| Total Operating Expenses | 21.72M | 22.11M | 21.82M | 20.58M | 17.73M |
| Operating Income | -5.43M | -4.33M | -3.33M | -3.76M | -4.48M |
| Income Before Tax | -5.49M | -4.35M | -3.64M | -4.08M | -4.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.49 | -4.35 | -3.64 | -4.08 | -4.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.35M | 1.95M | 1.52M | 1.30M | 1.26M |
| Net Income | -3.15M | -2.40M | -2.12M | -2.78M | -3.67M |
| EBIT | -5.43M | -4.33M | -3.33M | -3.76M | -4.48M |
| EBITDA | -5.25M | -4.19M | -3.22M | -3.65M | -4.39M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 1.20B | 1.19B | 1.18B | 1.17B | 1.16B |
| Average Diluted Shares Outstanding | 1.20B | 1.19B | 1.18B | 1.17B | 1.16B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |